Secretary of biotechnology development headquarter announced the acceptable and fair quantitative growth of biotechnology medications in Iran.

According to the public relations and information center of the Vice-Presidency for science and technology affairs, Mostafa Ghanei, secretary of biotechnology development headquarter, pointed out the growing trend of production of biology medications in the country, stating: high-tech medications have had significant growth since 2011. In fact, the growth and flourishing of biotechnology industry occurred in the 90s.

He continued: the most important growth factors in the area of biotechnology medications are “special attention of authorities toward this area”, “preparation of domestic instructions for production of this type of medications”, “prioritization of following up the requests for production of these medications”, “market monopoly for domestic products”, “prevention of import”, “proper pricing of products” and “export”.

Secretary of biotechnology development headquarter also affirmed: the biotechnology development headquarter will support the production of biology products in the country by knowledge-based companies.